Thromb Haemost 1987; 58(02): 772-777
DOI: 10.1055/s-0038-1645968
Original Article
Schattauer GmbH Stuttgart

The Isolation and Characterization of a Ternary Human Plasmin B-Chain-Streptokinase-Plasminogen Complex

Louis Summaria
1   The Section of Hemostasis and Thrombosis, Department of Surgery, Evanston Hospital, Evanston, lllinois
,
Irena Boreisha
2   The Department of Medicine, Pritzker School of Medicine, University of Chicago, Chicago, Illinois
,
Grant H Barlow
3   The Bioprocessing Research Center, Houston, Texas, USA
,
Kenneth C Robbins
2   The Department of Medicine, Pritzker School of Medicine, University of Chicago, Chicago, Illinois
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 27. November 1986

Accepted after revision 28. April 1987

Publikationsdatum:
27. Juni 2018 (online)

Preview

Summary

A ternary equimolar human plasmin B-chain-streptokinase-plasminogen complex was isolated from a mixture of the plasmin B-chain-streptokinase complex and human plasminogen at 0° C and 37° C. A ternary complex which was shown to be species specific, was identified and characterized by ultracentrifugal, acrylamide gel electrophoretic, and agarose double diffusion analyses. When mixed at a 1:1 molar ratio at 0° C, 39.9% of the preparation existed as a plasmin B-chain-streptokinase-plasmino-gen complex; when mixed at 37° C, 86.d% existed as a complex, which was identified by electrophoretic analyses to be a plasmin B-chain-streptokinase-plasmin complex. Sedimentation velocity analyses gave s°2o,w values of 3.79 for the plasmin B-chain-streptokinase complex, 4.10 for Lys-plasmin, and 6.23 for the plasmin B-chain-streptokinase-plasmin complex. Sedimentation equilibrium analyses gave molecular weights of 73,900 for the plasmin B-chain-streptokinase complex, 82,900 for Lys-plasmin, and 153,100 for the plasmin B-chain-streptokinase-plasmin complex. The diisopropylphosphorofluoridatc (DFP)-inhibitcd and the p-nitrophenyl-p-guanidino-benzoate (NPGB)-inhibited plasmin B-chain-streptokinase complexes both retained their ability to form a ternary complex with human plasminogen, but this complex did not convert to a plasmin B-chain-streptokinase-plasmin complex. Thus, the active site serine residue is essential for the activator activity of the plasmin B-chain-streptokinase complex, but it is not necessary for the binding of the plasmin B-chain-streptokinase complex to plasminogen to form a ternary complex.